← Leaderboards
Dmitri Artemov
Johns Hopkins University
$4,961,944
Attributed
$6,874,398
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $608.8K · FY2005–21$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$6,874,398 · 6
By mechanism
R01$5,807,115 · 3
R21$733,743 · 2
R56$333,540 · 1
Top collaborators
- Joseph M Backer5 shared
- Susanta K Sarkar5 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Jun O. Liu$22,989,575
- Arnold Bakker$10,680,906
- Daniel J Leahy$9,007,093
- Argye E. Hillis$28,779,519
- William Ramses Bishai$43,237,711
Others in their field
Top investigators on “Tumor”
- David Heimbrook · Leidos Biomedical Research, Inc.$636,492,067
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Gregory H Reaman · National Childhood Cancer Foundation$208,276,509
- Richard K. Wilson · Washington University$203,917,615
- Norman Wolmark · Nsabp Foundation, Inc.$177,323,696
- Ronald T Mitsuyasu · University Of California Los Angeles$138,361,819
Research focus
TumorMonitorResponseMalignant NeoplasmsSiteMalignant Breast NeoplasmMagnetic Resonance ImagingPropertyBreast Cancer ModelContrast MediaResistanceDesignCytotoxicMonoclonal AntibodiesLabelBlood VesselsRadiolabeledNanocarrierDrug CarriersErbb2 GeneHumanized AntibodyIn VivoPositron-Emission TomographyImage
Grant awards (18)
HER2-pretargeting image-guided therapy of breast cancer$387,251
R01 · FY2021 · CA · contact PI
HER2-pretargeting image-guided therapy of breast cancer$394,046
R01 · FY2020 · CA · contact PI
HER2-pretargeting image-guided therapy of breast cancer$382,225
R01 · FY2019 · CA · contact PI
HER2-pretargeting image-guided therapy of breast cancer$393,896
R01 · FY2018 · CA · contact PI
HER2-pretargeting image-guided therapy of breast cancer$404,441
R01 · FY2017 · CA · contact PI
Image-guided combination therapy: noninvasive assessment of delivery and response$562,844
R01 · FY2015 · CA · contact PI
Image-guided combination therapy: noninvasive assessment of delivery and response$550,634
R01 · FY2014 · CA · contact PI
Image-guided combination therapy: noninvasive assessment of delivery and response$550,456
R01 · FY2013 · CA · contact PI
Image-guided combination therapy: noninvasive assessment of delivery and response$595,990
R01 · FY2012 · CA · contact PI
Image-guided combination therapy: noninvasive assessment of delivery and response$608,757
R01 · FY2011 · CA · contact PI
Activated nano-sized MR contrast agents for imaging of tumor proteolytic activity$216,480
R21 · FY2010 · CA · contact PI
Activated nano-sized MR contrast agents for imaging of tumor proteolytic activity$180,400
R21 · FY2009 · CA · contact PI
MR Pharmacoangiography-Vascular Modulation of Delivery$333,540
R56 · FY2007 · CA · contact PI
MR Imaging of Endothelial Progenitor Cells in Prostate Cancer$181,538
R21 · FY2007 · CA · contact PI
MR Imaging of Endothelial Progenitor Cells in Prostate Cancer$155,325
R21 · FY2006 · CA · contact PI
MR Pharmacoangiography-Vascular Modulation of Delivery$327,409
R01 · FY2005 · CA
MR Pharmacoangiography-Vascular Modulation of Delivery$327,409
R01 · FY2004 · CA
MR Pharmacoangiography-Vascular Modulation of Delivery$321,757
R01 · FY2003 · CA